2.11
-0.08 (-3.74%)
| Penutupan Terdahulu | 2.19 |
| Jumlah Dagangan | 99,850 |
| Harga / Buku (P/B) | 1.32 |
| Julat 52 Minggu |
| Margin Keuntungan | -215.24% |
| Margin Operasi (TTM) | -242.68% |
| EPS Cair (TTM) | -0.220 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 18.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 16.10% |
| Nisbah Semasa (MRQ) | 3.80 |
| Aliran Tunai Operasi (OCF TTM) | -29.08 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -7.41 M |
| Pulangan Atas Aset (ROA TTM) | -49.03% |
| Pulangan Atas Ekuiti (ROE TTM) | -93.86% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Veru Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 1.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -2.5 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | 0.0 |
| Persekitaran Makro | -2.8 |
| AI Insight | NA |
| AI Technical | NA |
| Purata | -0.24 |
|
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 14.19% |
| % Dimiliki oleh Institusi | 33.43% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Purata Hasil Dividen 5T | 0.00% |
| Tarikh EX | Tarikh Pengumuman | Tarikh Pembayaran | Perincian |
|---|---|---|---|
| 28 Apr 2014 | 24 Mar 2014 | 07 May 2014 | 0.07 Tunai |
| 27 Jan 2014 | 16 Dec 2013 | 05 Feb 2014 | 0.07 Tunai |
| 28 Oct 2013 | 03 Oct 2013 | 06 Nov 2013 | 0.07 Tunai |
| 29 Jul 2013 | 15 Jul 2013 | 07 Aug 2013 | 0.07 Tunai |
| 28 Jan 2013 | 03 Jan 2013 | 06 Feb 2013 | 0.06 Tunai |
Hasil Dividen Tahunan
| Tahun | Dividen Tahunan ($) | Kekerapan/Tahun | Hasil % |
|---|---|---|---|
| 2014 | 0.140 | 2 | 0.36 |
| 2013 | 0.200 | 3 | 0.24 |
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |